Navigation Links
Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Date:1/14/2008

DALLAS and NEW HAVEN, Conn., Jan. 14 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) and RHEI Pharmaceuticals, Inc. ("RHEI"), a specialty pharmaceutical company focused on bringing proprietary medicines to the China market, today announced the signing of a definitive licensing agreement under which RHEI, which has more than 110 national sales representatives penetrating large volume hospitals, will market Access's proprietary product MuGard(TM) in the Peoples Republic of China and certain other Southeast Asian countries. MuGard(TM) has received marketing allowance from the U.S. Food and Drug Administration for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Oral mucositis has become a significant unmet medical need as a result of improved medical care in China and the Southeast Asian region. RHEI will be responsible for marketing MuGard in the People's Republic of China, Hong Kong, Macau, Taiwan, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam, as well as for manufacturing and for obtaining the necessary regulatory approvals for the product in the territory.

"We are pleased to have MuGard in our portfolio of products in China, building on our expertise in the area of oncology," said Dr. X. Sylvia He, Chief Executive Officer of RHEI. "Our mission is to bring innovative products to the Chinese market and MuGard fulfills a real medical need. With an increasing number of patients receiving radiation and chemotherapy in China, the prevalence of oral mucositis is growing. Our expert capabilities in sales and marketing, manufacturing and regulatory will help to maximize MuGard's potential in the marketplace."

"RHEI is a great partner for us in China," added Jeffrey B. Davis, Chief Executive Officer of Access. "We are excited about the potential for MuGard in China and believe RHEI is uniquely positioned to commercialize MuGar
'/>"/>

SOURCE Access Pharmaceuticals, Inc.; RHEI Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
2. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
3. Open access to health research publications
4. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
5. Care reforms raise concerns over patient access to GP services
6. Access Innovations Provides Support Services for Agis Network
7. RAND researchers offer options to improve immigrant health care quality, access
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Hispanics hypertension better controlled with equal access to care
10. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
11. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...heBerylCompanies,thenation,sleadingproviderofoutso...searnedrecognitionasoneofthetopoutsourcingfirmsinh...trademagazine.Berylwasrankedamongthepublication,st...lts,whichenabledittoclimbfromtwelfthplacein2007tot...ovativeproducts,suchasitsnewestlaunchofpost-discha...
(Date:11/23/2009)... as Best New Technology Provider for its QlikView ... Radnor, PA (PRWEB) November 23, 2009 -- Ql... Intelligence (BI) software company, today announc...nnovation™ Award in the Best New Technology ...ew. The award was presented at Everything Channel&...
(Date:11/23/2009)....Siegal,sDirectNutritionals,LLC,worldwidedistribut...ofwebsiteCookieDiet.com( www.CookieDiet.com ),toda...er-popularhunger-satisfyingcookiesareavailableonSa...tclub,Sam,sClub. ,, "We,reproudtowelcomeSamsclu...Siegal,sCookieDietproducts,andtheonlymembershipdis...
(Date:11/23/2009)...rst time, scientists have demonstrated that stem c...t of potential to become specialized cell types, w...der array of diseases and conditions than scientis..., a publication of Nature Publishing Group, the re...he Wake Forest Institute for Regenerative Medicine...
(Date:11/23/2009)...tment Underlines Moravia,s Commitment to the UK an...zech Republic (PRWEB) November 23, 2009 -- Moravia...der, announced today the appointment of George Kra... this new position, he will lead the established b...an overall responsibility for managing existing cu...
Breaking Medicine News(10 mins):Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 4Health News:Dr. Siegal's COOKIE DIET(R) Cookies Available at Samsclub.com 2Health News:New research shows versatility of amniotic fluid stem cells 2Health News:Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 2
...increases the likelihood that youth will engage in...f involved and supportive parenting, according to ...ublished in the February issue of the Journal of ...ronment to influence behavior. , "We found that ...
...rance Company is one of 10 employers across the co...ed Award. The award recognizes employers who demon...health. , , UnitedHealthcare provides health bene...plicants. Criteria included executive support for ...
...rming trend of,childhood obesity growing across th...m (SJHS) is partnering with American Academy of Pe...the development of a new comprehensive,program, He...igh School (1401 S. Grand Ave.) in Santa Ana with ...
... and older have prescription drug coverage today, ...ccording to a University of Michigan analysis. And...as the rich. , The analysis compares drug covera...g benefit started in 2006. The report, "Take-Up of...
...MD, FACC, FAHA, director of the Cardiac Catheteriz...Boston Medical Center is the recipient of the Drak...ne Scientific Session,s 59th annual conference in ...in the treatment of heart disease. He was also co-...
...tal benefits now place a higher value on that cove..., according to the National Association of Dental ... , , Almost two-thirds of employers, 62 percent,...ers with 250 to 999 employees--a 16-percent increa...
Other Medicine News:Health News:Study: Genetic risk for substance use can be neutralized by good parenting 2Health News:Texas Mutual Wins National Employee Wellness Award 2Health News:St. Joseph Health System Fights Childhood Obesity With New 'Healthy For Life' Program 2Health News:St. Joseph Health System Fights Childhood Obesity With New 'Healthy For Life' Program 3Health News:Most seniors have drug coverage, study shows 2Health News:Boston Medical Center cardiologist receives Drake Award 2Health News:NADP Study Reports Dramatic Increase in Value of Dental Benefits 2
(Date:11/20/2009)..., , WAYNE, Pa., Nov. 20 /PRNewswire-FirstCa... announced the results for its fiscal first quarte...quarter of fiscal 2010, product revenue decreased ...ing the three-month period ended September 30, 200... The Company reported the decreased net revenue o...
(Date:11/20/2009)..., , LARGO, Fla., Nov. 20 /PRNewswire-FirstC...VICF; TSX Venture Exchange: UVI), which develops, ...ecialty contact lenses, today reported its operati...0, 2009 (FY2010). ,, Net sales excluding royalt...ter, 4.4% less then $1,761,526 reported in the pre...
(Date:11/20/2009)..., , LOUISVILLE, Ky., Nov. 20 /PRNewswire...vestigators (NADDI) today announced a new initiati...ecursor Log Exchange (NPLEx) is a multi-state elec...itations on over-the-counter (OTC) medicines conta... sale. The technology for NPLEx is based on a sys...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 1Electronic Health Records Help Cardiac Patients Remain Healthy 53938 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 4Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 1Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 2Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 3
...scientific evidence supporting accuracy of, its ...or international conf... 7 Molecular,Biometrics, LLC, a privately-held me... for applications in personalized medicine to more...th and disease, presented data from,four new studi...
...ure Corporation,(Nasdaq: BPUR ) announced today t...Administration (FDA) on identifying an acceptable ...opure(R) [hemoglobin glutamer -,250 (bovine)], or ...opure,in patients suffering from Acute Myelogenous...components. Currently, AML patients who do not,acc...
Other Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3
Prechopper angled for soft cataracts
Prechopper angled
Dodick Nucleus Cracker
Dodick Irrigating Nucleus Chopper
Medicine Products: